RECALL OF METFORMIN EXTENDED RELEASE
In May 2020, the Food and Drug Administration (FDA) recommended that some makers of metformin extended release remove some of their tablets from the U.S. market. This is because an unacceptable level of a probable carcinogen (cancer-causing agent) was found in some extended-release metformin tablets. If you currently take this drug, call your healthcare provider. They will advise whether you should continue to take your medication or if you need a new prescription.
Metformin is a medication that doctors prescribe to treat type 2 diabetes and polycystic ovary syndrome. Some people have concerns that this drug may cause hair loss, but little evidence supports that claim.
Doctors sometimes also prescribe metformin for people with polycystic ovary syndrome (PCOS). Raised insulin and blood sugar levels are common symptoms of PCOS, and metformin can help reduce them.
In this article, we explore the possible relationship between metformin and hair loss, as well as relevant research. We also describe some of the treatment options for reducing the impact of hair loss if it does occur.